177 related articles for article (PubMed ID: 17926482)
1. [The evoluation of the strategy and tactics of treatment of Helicobacter pylori-dependent diseases].
Tsimmerman IaS
Klin Med (Mosk); 2007; 85(8):9-14. PubMed ID: 17926482
[TBL] [Abstract][Full Text] [Related]
2. [Indication for the treatment of Helicobacter pylori infection].
Svestka T; Krechler T; Brůha R; Jablonská M
Cas Lek Cesk; 2004; 143(12):850-3. PubMed ID: 15730218
[TBL] [Abstract][Full Text] [Related]
3. [Gastroduodenal diseases and Helicobacter pylori infection: overview].
Tsimmerman IaS
Klin Med (Mosk); 2009; 87(5):9-15. PubMed ID: 19565820
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori and non-malignant diseases.
Furuta T; Delchier JC
Helicobacter; 2009 Sep; 14 Suppl 1():29-35. PubMed ID: 19712165
[TBL] [Abstract][Full Text] [Related]
5. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III consensus and a third-line empirical regimen.
Rokkas T; Sechopoulos P; Robotis I; Margantinis G; Pistiolas D
Am J Gastroenterol; 2009 Jan; 104(1):21-5. PubMed ID: 19098844
[TBL] [Abstract][Full Text] [Related]
6. [Maastricht consensus-4 (2011). Main provisions and comments].
Tsimmerman IaS
Klin Med (Mosk); 2012; 90(9):28-34. PubMed ID: 23214010
[TBL] [Abstract][Full Text] [Related]
7. [The problem of growing resistance of microorganisms to antibiotic therapy and prospects for Helicobacter pylori eradication].
Tsimmerman IaS
Klin Med (Mosk); 2013; 91(6):14-20. PubMed ID: 24417061
[TBL] [Abstract][Full Text] [Related]
8. The current status of Helicobacter pylori as a pathogen in upper gastrointestinal tract.
Barbezat GO
N Z Med J; 1994 Nov; 107(990):478-80. PubMed ID: 7970364
[No Abstract] [Full Text] [Related]
9. Bactericidal activity of medicinal plants, employed for the treatment of gastrointestinal ailments, against Helicobacter pylori.
Zaidi SF; Yamada K; Kadowaki M; Usmanghani K; Sugiyama T
J Ethnopharmacol; 2009 Jan; 121(2):286-91. PubMed ID: 19041711
[TBL] [Abstract][Full Text] [Related]
10. [Microbial antagonism and rationale for the use of probiotics in combined therapy of Helicobacter pylori-related diseases].
Tsimmerman IaS; Subbotina LV; Neschisliaev VA
Klin Med (Mosk); 2010; 88(4):35-42. PubMed ID: 20919568
[TBL] [Abstract][Full Text] [Related]
11. Guidelines for clinical trials in Helicobacter pylori infection. Working Party of the European Helicobacter pylori Study Group.
Gut; 1997 Sep; 41 Suppl 2():S1-9. PubMed ID: 9404236
[No Abstract] [Full Text] [Related]
12. New strategies for Helicobacter pylori eradication.
Selgrad M; Malfertheiner P
Curr Opin Pharmacol; 2008 Oct; 8(5):593-7. PubMed ID: 18555746
[TBL] [Abstract][Full Text] [Related]
13. [Eradication efficiency and Helicobacter pylori resistance to antibiotics in anticipation of IV TH Maastricht consensus issues publication. Editorial].
Lazebnik LB; Bordin DS; Mikheeva OM; Belousova NL
Eksp Klin Gastroenterol; 2011; (8):3-7. PubMed ID: 22629748
[No Abstract] [Full Text] [Related]
14. Anti-Helicobacter pylori activity of plants used in Mexican traditional medicine for gastrointestinal disorders.
Castillo-Juárez I; González V; Jaime-Aguilar H; Martínez G; Linares E; Bye R; Romero I
J Ethnopharmacol; 2009 Mar; 122(2):402-5. PubMed ID: 19162157
[TBL] [Abstract][Full Text] [Related]
15. New guidelines for Helicobacter pylori: applying them to your practice.
Nimish V
Rev Gastroenterol Disord; 2007; 7(3):111-4. PubMed ID: 17928790
[TBL] [Abstract][Full Text] [Related]
16. [Helicobacter pylori].
Macipe Costa RM; Gimeno Feliu LA; Feja Solana T; Ruiz Ferrando E
Med Clin (Barc); 1996 Sep; 107(8):317. PubMed ID: 8965497
[No Abstract] [Full Text] [Related]
17. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Romano M; Iovene MR; Russo MI; Rocco A; Salerno R; Cozzolino D; Pilloni AP; Tufano MA; Vaira D; Nardone G
J Clin Pathol; 2008 Oct; 61(10):1112-5. PubMed ID: 18755715
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Helicobacter pylori infection.
O'Connor A; Gisbert J; O'Morain C
Helicobacter; 2009 Sep; 14 Suppl 1():46-51. PubMed ID: 19712168
[TBL] [Abstract][Full Text] [Related]
19. Treatment failures and secondary resistance to antibiotics. A growing concern in Helicobacter pylori therapy.
de Boer WA; Borody TJ
Dig Liver Dis; 2000 Nov; 32(8):673-5. PubMed ID: 11142575
[No Abstract] [Full Text] [Related]
20. Helicobacter pylori treatment: is sequential or quadruple therapy the answer?
Vakil N
Rev Gastroenterol Disord; 2008; 8(2):77-82. PubMed ID: 18641590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
